Table 2. Study treatment.
| Treatment | Caphosol plus SC (n = 108) |
Standard care (SC) (n = 107) |
All patients (N = 215) |
||||
|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | ||
| Radiotherapy | |||||||
| RT only | 44 | 40.7 | 39 | 36.4 | 83 | 38.6 | |
| CRT | Carboplatin | 22 | 20.3 | 31 | 29.0 | 53 | 24.7 |
| Cetuximab | 2 | 1.9 | 0 | 0 | 2 | 0.9 | |
| Cisplatin | 31 | 28.7 | 30 | 28.0 | 61 | 28.4 | |
| Cis/Carbo* | 9 | 8.4 | 7 | 6.6 | 16 | 7.4 | |
| Total | 64 | 59.3 | 68 | 63.6 | 132 | 61.4 | |
| Induction chemotherapy | |||||||
| No | 69 | 63.9 | 57 | 53.3 | 126 | 58.6 | |
| Yes | Carbo/5FU | 10 | 9.3 | 9 | 8.4 | 19 | 8.8 |
| Cis/5FU | 27 | 25.0 | 36 | 33.6 | 63 | 29.3 | |
| Cis/5FU & Carbo/5FU | 2 | 1.8 | 5 | 4.7 | 7 | 3.3 | |
| Total | 39 | 36.1 | 50 | 46.7 | 89 | 41.4 | |
| Technique | |||||||
| Bilateral | 80 | 74.1 | 77 | 72.0 | 157 | 73.0 | |
| Unilateral | 28 | 25.9 | 30 | 28.0 | 58 | 27.0 | |
| Technique | |||||||
| 3D-Conformal | 13 | 12.0 | 7 | 6.5 | 20 | 9.3 | |
| IMRT | 95 | 88.0 | 100 | 93.5 | 195 | 90.7 | |
| RT breaks | |||||||
| No | 104 | 96.3 | 102 | 95.3 | 206 | 95.8 | |
| Yes | 4 | 3.7 | 5 | 4.7 | 9 | 4.2 | |
*
Cisplatin Day 1 switched to carboplatin Day 29